Sofia Gustafsson Email

Senior Scientist . BioArctic

Current Roles

Employees:
129
Revenue:
$20M
About
BioArctic AB is a Swedish research based biopharma company focusing on disease modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. The company also develops a potential treatment for Complete Spinal Cord Injury. BioArctic focuses on innovative treatments in areas with high unmet medical needs. \n\nCollaborations with universities are of great importance to the company together with our strategically important global partners in the Alzheimer (Eisai) and Parkinson (AbbVie) projects. The project portfolio is a combination of fully funded projects run in partnership with global pharmaceutical companies and innovative in-house projects with significant market- and out-licensing potential. www.bioarctic.se
BioArctic Address
Warfvinges väg 35
Stockholm, null
SWE
BioArctic Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.